Alternative Investments - Gold, REITs, Crypto, Commodities, etc.
Tag: featured-insiders
🌿 Innovative Industrial Properties ($IIPR): $1M Insider Buy, 14.7% Yield & the Biotech Pivot 🌿🧪
Innovative Industrial Properties ($IIPR) is stirring up an extraordinary investment debate. Its executive chairman just invested $1 million in preferred shares, the common stock offers an indicated dividend yield near 14.7%, institutional ownership approaches 80%, and short interest exceeds 15%. Meanwhile, a $270 million life sciences investment could reshape this battered cannabis REIT. Is IIPR an overlooked income-and-recovery opportunity—or a dividend trap? We examine the evidence through the FunStock Method™. FunStock Index™: 7.65/10. 🌿🧪
🏦 Kayne Anderson BDC (KBDC): A $5.2M Insider Buy, 12.3% Yield—and the BDC Trap 💰⚡
Kayne Anderson BDC Chairman Jim Robo just put $5.2 million behind KBDC near $13. Add a 12.3% yield, deep discount to NAV and covered dividend, and the stock looks irresistible—until you examine NAV erosion, leverage and private-credit risk.
🦾 IperionX (IPX): The Titanium Disruptor Powering America’s Supply Chain Revolution
IperionX (IPX) is turning from a science experiment into a 24/7 titanium production story—with insiders buying, institutions circling, and the U.S. government backing the mission. The upside looks massive. So do the risks.
Alexandria Real Estate (ARE): The Life Science “Dr. Frankenstein” Pivot — Rebuilding the Lab from the Floor Up
Alexandria Real Estate (ARE) is the king of life science labs—and one of the most punished REITs of the last five years. After a brutal dividend cut, asset write-downs, and a 75% drawdown, the founder just bought $1.3M of stock and the company is buying back shares. Is this a broken experiment—or a classic cycle-bottom setup?